Forbes March 18, 2025
Joshua P. Cohen

Despite bipartisan support, a last-ditch effort to pass a healthcare package that included pharmacy benefit manager reforms was scuttled last week. This marks the umpteenth time that lawmakers couldn’t cross the threshold to pass and enact changes to how PBMs do business.

It’s not for lack of congressional hearings on PBM reform over the years, or the introduction of numerous bills that include provisions directed at potentially anti-competitive practices. Lawmakers on both sides of the aisle agree that changes are needed.

The legislative initiatives center around issues such as spread pricing, which is a practice where PBMs charge health plans or employers a higher price for medications than what they pay to pharmacies, keeping the difference (spread) as profit. Bills...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
The Download: speaking to robots, and growing pharmaceutical mushrooms
AI, patient data firms aim to speed up drug development
Arbor raises $74M amid genetic medicine’s funding slump
HHS files brief in 340B rebate model case: 4 takeaways
Latigo raises $150M to get non-opioid pain drugs through key tests

Share This Article